Marinus Pharma (NASDAQ:MRNS) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:01 AM.
Here’s what investors need to know about the announcement.
Earnings
Marinus Pharma beat estimated earnings by 6.94%, reporting an EPS of $-0.67 versus an estimate of $-0.72.
Revenue was down $3.81 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 5.33% increase in the share price the next day.
Here’s a look at Marinus Pharma’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.70 | 0.47 | -0.68 | -0.85 |
| EPS Actual | -0.76 | -0.94 | -1.06 | -0.52 |
| Revenue Estimate | 5.35M | 29.48M | 2.31M | 2.28M |
| Revenue Actual | 7.16M | 2.34M | 1.79M | 14.19M |
To track all earnings releases for Marinus Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
